Systemic Hypothermia in Acute Cervical Spinal Cord Injury
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- University of Miami
- Study ID
- NCT02991690
- Status
- Recruiting
Conditions
- Spinal Cord Injury, Acute
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Hypothermia — OTHERTo deliver intravascular hypothermia, an Alsius Icy CoolGuard® catheter (US Food and Drug Administration approved, Premarket Notification \[510(k), K030421\]; Alsius Corporation, Irvine, California) will be inserted through the femoral vein using a sterile technique. Patients will be cooled at a maximum rate (2-2.5 ºC/hr.) until they reach the target temperature (T 33 ºC), which will be maintained for 48 hours, and then re-warmed at 0.1 ºC/hr. until normothermia (T 37ºC) is achieved.
Study Details
This study is a prospective multi-center trial designed to determine the safety profile and efficacy of modest (33ºC) intravascular hypothermia following acute cervical (C1 to C8) Spinal Cord Injury (SCI).
Key Dates
- Start date
- Aug 4, 2017
- Status verified
- Nov 2025
- Primary completion
- Aug 31, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: HypothermiaIntravascular hypothermia will be initiated within 24 hours post-injury and 33 degrees Celsius will be maintained for 48 hours.
- No Intervention: ControlStandard of care medical treatment, specific to each individual.
Primary Outcome Measure
Neurological improvement on American Spinal Injury Association (ASIA) [ Time Frame: Between baseline and 12 months ]
Central Contacts
- George Jimsheleishvili, MD305-243-4781
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| HonorHealth Research Institute with Barrow Brain and Spine | Phoenix | Arizona | 85027 | |
| Jackson Memorial Hospital | Miami | Florida | 33136 | George Jimsheleishvili, MD 305-243-4781 |
| Emory University School of Medicine | Atlanta | Georgia | 30303-3049 | - |
| Indiana University School of Medicine | Indianapolis | Indiana | 46202-1000 | - |
| University of Maryland School of Medicine | Baltimore | Maryland | 21201 | |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107-5125 | James Harrop, MD |
| Prisma Health - University of South Carolina | Columbia | South Carolina | 29203 |
Find similar trials in Phoenix, AZ
By research site
HonorHealth Research Institute with Barrow Brain and Spine· Phoenix, AZJackson Memorial Hospital· Miami, FLEmory University School of Medicine· Atlanta, GAIndiana University School of Medicine· Indianapolis, INUniversity of Maryland School of Medicine· Baltimore, MDThomas Jefferson University· Philadelphia, PA
Related Studies
- A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord InjuryPHASE1 · Recruiting · Lineage Cell Therapeutics, Inc. · Downey, California
- Duraplasty for Acute Traumatic Spinal Cord InjuryEnrolling By Invitation · University of California, San Francisco · San Francisco, California